Volume 21; Issue 9

Main
The Lancet Oncology
Volume 21; Issue 9

The Lancet Oncology

Volume 21; Issue 9

1

The science of hope

Corn, Benjamin W, Feldman, David B, Wexler, Isaiah

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 56 KB

2020

2

Turning up the heat on non-immunoreactive tumours: opportunities for clinical development

Ochoa de Olza, MarÃa, Navarro Rodrigo, Blanca, Zimmermann, Stefan, Coukos, George

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 61 KB

2020

3

Multiple brown papules at the site of mastectomy for breast cancer

Bourlond, Florence, Lipsker, Dan

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 629 KB

2020

4

Development of paediatric non-stage prognosticator guidelines for population-based cancer registries and updates to the 2014 Toronto Paediatric Cancer Stage Guidelines

Gupta, Sumit, Aitken, Joanne, Bartels, Ute, Bhakta, Nickhill, Bucurenci, Mihaela, Brierley, James D, De Camargo, Beatriz, Chokunonga, Eric, Clymer, Jessica, Coza, Dana, Fraser, Chris, Fuentes-Alabi, S

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 61 KB

2020

5

Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy

Bodei, Lisa, SchÃ¶der, Heiko, Baum, Richard P, Herrmann, Ken, Strosberg, Jonathan, Caplin, Martyn, Ãberg, Kjell, Modlin, Irvin M

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 67 KB

2020

6

Risk factors for in-hospital mortality in patients with cancer and COVID-19

Zhang, Guosen, An, Yang, Zhang, Lu, Xie, Longxiang, Guo, Xiangqian

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 32 KB

2020

7

20 years of The Lancet Oncology: how scientific should oncology be?

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 593 KB

2020

8

Open notes in cancer care: coming soon to patients

Blease, Charlotte, Salmi, Liz, DesRoches, Catherine M

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 124 KB

2020

9

Drug repurposing for cancer treatments: a well-intentioned, but misguided strategy

Tran, Audrey A, Prasad, Vinay

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 105 KB

2020

10

Risk factors for in-hospital mortality in patients with cancer and COVID-19

Guo, Kaibo, Sun, Leitao, Yuan, Li, Wasan, Harpreet S, Ruan, Shanming

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 33 KB

2020

11

Carboplatin plus etoposide or topotecan for small-cell lung cancer

Arrieta, Oscar, Lara-MejÃa, Luis, Zatarain-BarrÃ³n, Zyanya Lucia

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 133 KB

2020

12

Atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma

Yangâ , Xu, Wangâ , Dongxu, Lin, Jianzhen, Yang, Xiaobo, Zhao, Haitao

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 33 KB

2020

13

Terminal agitation and delirium in patients with cancer

Kako, Jun, Ishiki, Hiroto, Kajiwara, Kohei

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 32 KB

2020

14

Ripretinib for advanced gastrointestinal stromal tumours

Dekker, Tim J A

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 32 KB

2020

15

Terminal agitation and delirium in patients with cancer

SchlÃ¶gl, Mathias, Jones, Christopher A, Riese, Florian

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 33 KB

2020

16

Head and neck surgery recommendations during the COVID-19 pandemic

Galloway, Thomas J, Kowalski, Luiz Paulo, Matos, Leandro L, Junior, Gilberto Castro, Ridge, John A

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 33 KB

2020

17

Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial

Al-Sawaf, Othman, Zhang, Can, Tandon, Maneesh, Sinha, Arijit, Fink, Anna-Maria, Robrecht, Sandra, Samoylova, Olga, Liberati, Anna M, Pinilla-Ibarz, Javier, Opat, Stephen, Sivcheva, Liliya, Le DÃ», Kat

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 60 KB

2020

18

Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial

Baize, Nathalie, Monnet, Isabelle, Greillier, Laurent, Geier, Margaux, Lena, HervÃ©, Janicot, Henri, Vergnenegre, Alain, Crequit, Jacky, Lamy, Regine, Auliac, Jean-Bernard, Letreut, Jacques, Le Caer,

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 68 KB

2020

19

Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in

Nowak, Anna K, Lesterhuis, W Joost, Kok, Peey-Sei, Brown, Chris, Hughes, Brett GM, Karikios, Deme J, John, Thomas, Kao, Steven C-H, Leslie, Connull, Cook, Alistair M, Pavlakis, Nick, Briscoe, Karen, O

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 65 KB

2020

20

Gender balance at oncology conferences in China

Biskup, Ewelina, Xin, Zhaochen, Khanna, Kajal, Leung, Tiffany I, Zhang, Hongwei

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 102 KB

2020

21

Apatinib in patients with advanced chordoma: a single-arm, single-centre, phase 2 study

Liu, Chao, Jia, Qi, Wei, Haifeng, Yang, Xinghai, Liu, Tielong, Zhao, Jian, Ling, Yan, Wang, Chenguang, Yu, Hongyu, Li, Zhenxi, Jiao, Jian, Wu, Zhipeng, Yang, Cheng, Xiao, Jianru

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 62 KB

2020

22

Risk factors for in-hospital mortality in patients with cancer and COVID-19 â Authors' reply

Yang, Kunyu, Sheng, Yuhan, Wu, Bian, Wu, Gang

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 31 KB

2020

23

Correction to Lancet Oncol 2020; 21: 1017â18

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 29 KB

2020

24

Terminal agitation and delirium in patients with cancer â Authors' reply

Hui, David, De La Rosa, Allison, Wu, Jimin, Bruera, Eduardo

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 33 KB

2020

25

Atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma â Authors' replys

Lee, Kyung-Hun, Lee, Michael S

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 32 KB

2020

26

The Lancet Oncology at 20âtwo decades of influencing the oncology landscape

Collingridge, David

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 44 KB

2020

27

Ripretinib for advanced gastrointestinal stromal tumours â Authors' reply

Blay, Jean-Yves, von Mehren, Margaret

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 34 KB

2020

28

Head and neck surgery recommendations during the COVID-19 pandemic â Author's reply

Mehanna, Hisham

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 29 KB

2020

29

Vision 2020: looking back and thinking forward on The Lancet Oncology Commissions

Gospodarowicz, Mary K, Jaffray, David A, Knaul, Felicia M

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 42 KB

2020

30

Venetoclax plus obinutuzumab therapy for front-line treatment of chronic lymphocytic leukaemia

Seymour, John F

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 187 KB

2020

31

Acting on misinformation to prevent patient harm

The Lancet Oncology,

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 113 KB

2020

32

Correction to Lancet Oncol 2020; 21: 1125â26

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 29 KB

2020

33

Correction to Lancet Oncol 2020; 21: 935â46

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 29 KB

2020

34

Patients with cancer hit hard by deadly explosions in Beirut

Gourd, Elizabeth

Journal:

The Lancet Oncology

Year:

2020

File:

PDF, 114 KB

2020